Body image, symptoms and insight in chronic schizophrenia

Psychiatry and Clinical Neurosciences
Reiko KoideNobuaki Morita

Abstract

Historically, schizophrenics' body image problems were regarded as related particularly to delusions and hallucinations. However, during the 1980s, the predominant view of the phenomenology of the disorder broadened to include negative symptoms; deviations in schizophrenics' body image underlie various behaviors or allegations concerning the body and should be refocused. The present study attempted to detect body image deviations in chronic schizophrenia using the Body Image Questionnaire (BIQ), which comprises three hypothetical components (anatomical, functional and other psychological components), and to clarify their related clinical characteristics in symptoms and insight. The BIQ was administered to 93 chronic schizophrenics (diagnosed according to DSM IV; 44 men and 49 women) and 177 normals (78 men and 99 women) adults. The combined data of the three BIQ components in schizophrenic and normal subjects were factor-analyzed separately, and factor scores obtained were compared between schizophrenic and normal groups. The factor scores that differentiated groups were further compared between schizophrenic subgroups, determined by high or low scores for positive symptoms assessed by Scale for the Assessment of Positive Sympt...Continue Reading

References

Jun 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·F H Connolly, M Gipson
Aug 1, 1978·Journal of Abnormal Psychology·L J ChapmanM L Raulin
Nov 1, 1992·General Hospital Psychiatry·C K Sonneborn, P M Vanstraelen
Jan 1, 1992·Psychotherapy and Psychosomatics·P Snaith
Jan 1, 1991·Psychopathology·T Martin, W F Gattaz
Jan 1, 1991·Schizophrenia Bulletin·X F AmadorJ M Gorman
Jun 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·A S David
Sep 1, 1990·General Hospital Psychiatry·S H RosenthalB Coffey
Nov 1, 1989·Comprehensive Psychiatry·J de LeonG M Simpson
Jan 1, 1988·Journal of Pain and Symptom Management·R H Dworkin, E Caligor
May 1, 1988·Comprehensive Psychiatry·M D Feldman
Oct 1, 1986·The Journal of Nervous and Mental Disease·S Blackmore
Mar 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·G G Hay
Apr 1, 1982·The American Journal of Psychiatry·S W TwemlowF C Jones
Nov 1, 1982·Psychiatry·G O GabbardF C Jones
Sep 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·I McGilchrist, J Cutting
Mar 1, 1994·Journal of Psychiatric Research·S Lautenbacher, J C Krieg
Oct 1, 1994·Archives of General Psychiatry·X F AmadorJ M Gorman
Oct 1, 1994·Fortschritte der Neurologie-Psychiatrie·D Schmoll
Jan 1, 1994·Schizophrenia Bulletin·M J Cuesta, V Peralta
Feb 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·R GuieuH Coulouvrat
Nov 1, 1993·The Journal of Nervous and Mental Disease·K A Phillips, S L McElroy
Sep 1, 1993·The Journal of Nervous and Mental Disease·M WeiserM Neuman
Jan 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·T E GoldbergD R Weinberger
Aug 1, 1996·Journal of Abnormal Psychology·M J ColemanP S Holzman
Jul 23, 1999·Schizophrenia Bulletin·M F Green, K H Nuechterlein

❮ Previous
Next ❯

Citations

Apr 1, 2009·The Clinical Journal of Pain·Olivier BonnotSylvie Tordjman
Dec 31, 2014·Schizophrenia Research and Treatment·Ravi Philip Rajkumar
Sep 9, 2008·La Presse médicale·Olivier Bonnot, Sylvie Tordjman
Mar 3, 2009·L'Encéphale·C Farrer, N Franck
Sep 27, 2005·Consciousness and Cognition·Frédérique de VignemontNicolas Franck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.